Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating activities:
Net income	$ 8,319	$ 4,049
Reconciliation of net income to net cash (used in) provided by operating activities:
Depreciation, amortization and accretion	9,176	9,151
Impairments and other charges	0	518
Gain on investments	(662)	(257)
Equity-based compensation expense	1,778	1,860
Recovery of credit losses	(23)	(85)
Amortization and expense of financing costs	570	495
Gain on sale of assets	(127)	(113)
Non-cash cumulative foreign currency translation adjustment loss from dissolution of Canadian subsidiary	0	9,516
Deferred income tax expense (benefit)	1,102	(134)
Other non-cash (credits) charges	(1)	6
Changes in operating assets and liabilities:
Accounts receivable	(17,375)	(15,584)
Inventories	(3,906)	(2,663)
Prepaid expenses and other current assets	2,789	6,158
Trade accounts payable and accrued expenses	(13,300)	(9,277)
Other	(196)	295
Net cash provided by (used in) operating activities	(11,856)	3,935
Investing activities:
Purchases of property, plant and equipment, net	(19,019)	(17,956)
Proceeds from sale of investments	0	19,011
Proceeds from sale of property, plant and equipment	127	182
Other investing activities	164	108
Net cash (used in) provided by investing activities	(18,728)	1,345
Financing activities:
Proceeds from credit agreements and long-term debt	105	96
Principal payments on credit agreements and long-term debt	(105)	(96)
Payments on financing lease obligations	(1,166)	(931)
Proceeds from exercise of stock options	371	0
Taxes paid upon vesting of equity-based compensation	(5,928)	(1,158)
Net cash used in financing activities	(6,723)	(2,089)
Effect of exchange rate changes on cash	151	651
(Decrease) increase in cash and cash equivalents	(37,156)	3,842
Cash, cash equivalents and restricted cash at beginning of period	72,680	37,208
Cash, cash equivalents and restricted cash at end of period	35,524	41,050
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets
Cash and cash equivalents at end of period	35,473	41,000
Restricted cash at end of period	51	50
Total cash, cash equivalents and restricted cash at end of period shown in the consolidated statements of cash flows	$ 35,524	$ 41,050